Results 121 to 130 of about 6,499,787 (384)
Molecular Oncology, EarlyView.In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen +13 more
wiley +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
Revista de la Facultad de Ciencias de la Salud, 2012 It seems obvious, but for teaching in health sciences faculties, it is not enough to be a doctor or specialist. In fact, “medical education” is taught as a specialty in many universities of the country.
Mario Delgado-Noguera
doaj
Nonparametric Cusum Charts for Angular Data with Applications in Health Science and Astrophysics [PDF]
arXiv, 2017 This paper develops non-parametric rotation invariant CUSUMs suited to the detection of changes in the mean direction as well as changes in the concentration parameter of angular data. The properties of the CUSUMs are illustrated by theoretical calculations, Monte Carlo simulation and application to sequentially observed angular data from health ...
arxiv
The Scoop, Vol. 5 Issue 1, April 2018 [PDF]
, 2018 Latest news and events from the Health Sciences Library in our monthly newsletter for April 2018.https://stars.library.ucf.edu/scoop-vol5/1000/thumbnail ...
Library, Health Sciences
core +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
The Scoop, Vol. 5 Issue 12, March 2019 [PDF]
, 2019 Latest news and events from the Health Sciences Library in our monthly newsletter for March 2019.https://stars.library.ucf.edu/scoop-vol5/1010/thumbnail ...
Library, Health Sciences
core +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
Quantum Readiness in Healthcare and Public Health: Building a Quantum Literate Workforce [PDF]
arXivQuantum technologies, including quantum computing, cryptography, and sensing, among others, are set to revolutionize sectors ranging from materials science to drug discovery. Despite their significant potential, the implications for public health have been largely overlooked, highlighting a critical gap in recognition and preparation.
arxiv
The Scoop, Vol. 4 Issue 8, November 2017 [PDF]
, 2017 Latest news and events from the Health Sciences Library in our monthly newsletter for November 2017.https://stars.library.ucf.edu/scoop-vol4/1006/thumbnail ...
Library, Health Sciences
core +1 more source